PROGENY FORGED COCR CEMENTED FEMORAL COMPONENT

K001984 · Stelkast Company · JDG · Sep 27, 2000 · Orthopedic

Device Facts

• Record ID: K001984
• Device Name: PROGENY FORGED COCR CEMENTED FEMORAL COMPONENT
• Applicant: Stelkast Company
• Product Code: JDG · Orthopedic
• Decision Date: Sep 27, 2000
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3360
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

1. Joint impairment from arthritis (rheumatoid, osteo and post traumatic). 2. Revision of failed femoral head replacements. 3. When alternative reconstructive techniques are not viable. 4. When arthrodesis is contraindicated. 5. Avascular necrosis or fracture of the femoral head. 6. Congenital defects that will allow adequate function of the system.

Device Story

Progeny Forged CoCr Cemented Femoral Component is a prosthetic hip implant; intended for cemented fixation in femoral canal. Device replaces femoral head in total hip arthroplasty; addresses joint impairment from arthritis, necrosis, fracture, or failed prior replacements. Used by orthopedic surgeons in clinical/hospital settings. Provides structural support for hip joint; restores mobility; reduces pain. Device is a passive orthopedic implant; no electronic or software components.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Forged Cobalt-Chromium (CoCr) alloy femoral component; designed for cemented fixation. Passive orthopedic implant; no energy source or software.

Indications for Use

Indicated for patients with joint impairment due to rheumatoid, osteoarthritis, or post-traumatic arthritis; revision of failed femoral head replacements; avascular necrosis or fracture of the femoral head; or congenital defects where alternative reconstructive techniques are not viable and arthrodesis is contraindicated.

Regulatory Classification

Identification

A hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis is a device intended to be implanted to replace a portion of the hip joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum. This generic type of device includes designs which are intended to be fixed to the bone with bone cement (§ 888.3027) as well as designs which have large window-like holes in the stem of the device and which are intended for use without bone cement. However, in these latter designs, fixation of the device is not achieved by means of bone ingrowth.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an emblem of a stylized eagle.

## SEP 2 7 2000

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Donald A. Stevens President StelKast Company 800 Vinial Street Suite B-210 Pittsburgh, Pennsylvania 15212

Re: K001984

Trade Name: Progeny Forged CoCr Cemented Femoral Component Regulatory Class: II Product Code: JDG Dated: June 27, 2000 Received: June 29, 2000

Dear Mr. Stevens:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations ( Femanel 1 pp 3 v 4 , a be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

Page 2 - Mr. Donald A. Stevens

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its Internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Mark N Millinson

Celia M. Witten, Ph.D., M.D. Division Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(K) Number (if known):

Progeny Forged CoCr Cemented Femoral Component Device Name:

Indications For Use:

- 1. Joint impairment from arthritis (rheumatoid, osteo and post traumatic).
- 2. Revision of failed femoral head replacements.
- 3. When alternative reconstructive techniques are not viable.
- 4. . When arthrodesis is contraindicated.
- 5. Avascular necrosis or fracture of the femoral head.
- 6. Congenital defects that will allow adequate function of the system.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

## Concurrence of CDRH, Office of Device Evaluation (ODE)

OR

Mark M. Millenson

(Division Sign-Off) (Division Sign-Oir)
Division of General Restorative Devices 00 1984 510(k) Number -

Prescription Use (Per 21 CFR 801.109) Over-The-Counter Use

(Optional Format 1-2-96)